Payment overview · 2025
General Payments
$283.74
9 reported records · 6 companies
Healthcare provider profile · identity verified
Ronald Cable, DO
Allopathic & Osteopathic Physicians|Family Medicine · OKLAHOMA CITY, OK · NPI 1467430900
Verified facts
What the public records show
CMS Open Payments records show Ronald Cable, DO received $283.74 in general payments during 2025 across 9 reported records.
ACADIA Pharmaceuticals Inc accounted for 44.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Aristada, Ingrezza, Nuplazid, Rexulti.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 45 claims for Nuplazid by this doctor in 2024.
Alkermes, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARISTADA as an associated drug or biological on 76041 records involving 17486 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Aristada by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABILIFY MAINTENA as an associated drug or biological on 2902 records involving 986 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Abilify Maintena by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Rexulti by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 137 claims for Ingrezza by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABILIFY MAINTENA as an associated drug or biological on 27924 records involving 10497 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Abilify Maintena by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 121 claims for Nuedexta by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $125.00 | 44.0% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $57.72 | 20.3% | 3 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $44.53 | 15.7% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $21.83 | 7.7% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $19.57 | 6.9% | 1 | 2025 |
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $15.09 | 5.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $283.74 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $79.55 | 4 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $44.53 | 2 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $19.57 | 1 | 2025 |
Source payment records
|
|||||
| ARISTADA Normalized: aristada |
Drug | Alkermes, Inc. | $15.09 | 1 | 2025 |
Source payment records
|
|||||
| LYBALVI Normalized: lybalvi |
Drug | Alkermes, Inc. | $15.09 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ARISTADA aristada |
2025 | Aristada | 2024 | 31 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 137 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 45 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 18 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
45 | suppressed by CMS |
| Alkermes, Inc. Exact reporting entity; no affiliate inference |
2025 | ARISTADA open payments reported associated product |
CMS Open Payments — General Payments 76041 supporting records · 17486 recipient NPIs · example record 1222428566 |
Aristada · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | ABILIFY MAINTENA open payments reported associated product |
CMS Open Payments — General Payments 2902 supporting records · 986 recipient NPIs · example record 1251759994 |
Abilify Maintena · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
137 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | ABILIFY MAINTENA open payments reported associated product |
CMS Open Payments — General Payments 27924 supporting records · 10497 recipient NPIs · example record 1227267721 |
Abilify Maintena · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
121 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2272 | 368 |
| Eliquis | Apixaban | 2040 | 217 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1948 | 265 |
| Gabapentin | Gabapentin | 1623 | 271 |
| Furosemide | Furosemide | 1528 | 258 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1298 | 224 |
| Amlodipine Besylate | Amlodipine Besylate | 1230 | 223 |
| Potassium Chloride | Potassium Chloride | 1109 | 212 |
| Trazodone Hcl | Trazodone Hcl | 1101 | 191 |
| Mirtazapine | Mirtazapine | 994 | 180 |
| Lisinopril | Lisinopril | 988 | 175 |
| Metoprolol Tartrate | Metoprolol Tartrate | 834 | 162 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 817 | 220 |
| Omeprazole | Omeprazole | 790 | 167 |
| Tamsulosin Hcl | Tamsulosin Hcl | 785 | 150 |
| Metformin Hcl | Metformin Hcl | 716 | 116 |
| Divalproex Sodium | Divalproex Sodium | 713 | 110 |
| Famotidine | Famotidine | 684 | 112 |
| Carvedilol | Carvedilol | 679 | 131 |
| Sertraline Hcl | Sertraline Hcl | 678 | 108 |
| Buspirone Hcl | Buspirone Hcl | 673 | 116 |
| Clopidogrel | Clopidogrel Bisulfate | 517 | 106 |
| Levetiracetam | Levetiracetam | 510 | 72 |
| Donepezil Hcl | Donepezil Hcl | 498 | 85 |
| Duloxetine Hcl | Duloxetine Hcl | 467 | 77 |
| Escitalopram Oxalate | Escitalopram Oxalate | 458 | 80 |
| Metoprolol Succinate | Metoprolol Succinate | 443 | 94 |
| Citalopram Hbr | Citalopram Hydrobromide | 418 | 60 |
| Fluticasone Propionate | Fluticasone Propionate | 399 | 119 |
| Tramadol Hcl | Tramadol Hcl | 386 | 109 |
| Losartan Potassium | Losartan Potassium | 366 | 74 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 348 | 59 |
| Meloxicam | Meloxicam | 343 | 58 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 342 | 182 |
| Olanzapine | Olanzapine | 340 | 58 |
| Hydralazine Hcl | Hydralazine Hcl | 332 | 69 |
| Quetiapine Fumarate | Quetiapine Fumarate | 319 | 61 |
| Oxybutynin Chloride | Oxybutynin Chloride | 315 | 44 |
| Memantine Hcl | Memantine Hcl | 314 | 62 |
| Fluoxetine Hcl | Fluoxetine Hcl | 305 | 44 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 295 | 62 |
| Ondansetron Hcl | Ondansetron Hcl | 284 | 122 |
| Lorazepam | Lorazepam | 278 | 52 |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 275 | 69 |
| Ropinirole Hcl | Ropinirole Hcl | 270 | 36 |
| Sucralfate | Sucralfate | 270 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 267 | 54 |
| Tizanidine Hcl | Tizanidine Hcl | 267 | 51 |
| Jardiance | Empagliflozin | 254 | 26 |
| Clonidine Hcl | Clonidine Hcl | 248 | 63 |
| Clozapine | Clozapine | 242 | 22 |
| Benztropine Mesylate | Benztropine Mesylate | 231 | 27 |
| Montelukast Sodium | Montelukast Sodium | 225 | 42 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 223 | 46 |
| Risperidone | Risperidone | 220 | 47 |
| Methocarbamol | Methocarbamol | 218 | 50 |
| Allopurinol | Allopurinol | 215 | 48 |
| Loperamide | Loperamide Hcl | 215 | 84 |
| Myrbetriq | Mirabegron | 213 | 17 |
| Simvastatin | Simvastatin | 213 | 42 |
| Oxycontin | Oxycodone Hcl | 212 | 32 |
| Pregabalin | Pregabalin | 212 | 36 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 209 | 47 |
| Amiodarone Hcl | Amiodarone Hcl | 208 | 48 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 203 | 52 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 202 | 102 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 199 | 23 |
| Prednisone | Prednisone | 198 | 71 |
| Enulose | Lactulose | 194 | 41 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 187 | 32 |
| Vraylar | Cariprazine Hcl | 187 | 12 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 184 | 46 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 177 | 45 |
| Lamotrigine | Lamotrigine | 176 | 26 |
| Tradjenta | Linagliptin | 173 | 12 |
| Trintellix | Vortioxetine Hydrobromide | 173 | 11 |
| Latanoprost | Latanoprost | 172 | 27 |
| Novolog Flexpen | Insulin Aspart | 169 | 35 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 168 | 26 |
| Finasteride | Finasteride | 168 | 28 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 163 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 162 | 41 |
| Oxycodone Hcl | Oxycodone Hcl | 161 | 44 |
| Ozempic | Semaglutide | 159 | 22 |
| Ondansetron Odt | Ondansetron | 157 | 93 |
| Xarelto | Rivaroxaban | 156 | 17 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 154 | 49 |
| Doxycycline Hyclate | Doxycycline Hyclate | 153 | 101 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 151 | 50 |
| Insulin Aspart Flexpen | Insulin Aspart | 150 | 47 |
| Metolazone | Metolazone | 145 | 46 |
| Baclofen | Baclofen | 137 | 28 |
| Ingrezza | Valbenazine Tosylate | 137 | suppressed |
| Aripiprazole | Aripiprazole | 135 | 24 |
| Midodrine Hcl | Midodrine Hcl | 134 | 35 |
| Gemtesa | Vibegron | 133 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 129 | 21 |
| Glipizide | Glipizide | 128 | 30 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 127 | 126 |
| Digoxin | Digoxin | 126 | 24 |
| Nystatin | Nystatin | 126 | 53 |
| Spironolactone | Spironolactone | 126 | 33 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 124 | 18 |
| Megestrol Acetate | Megestrol Acetate | 123 | 26 |
| Divalproex Sodium Er | Divalproex Sodium | 121 | 20 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 121 | suppressed |
| Januvia | Sitagliptin Phosphate | 117 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 116 | 41 |
| Levofloxacin | Levofloxacin | 115 | 105 |
| Meclizine Hcl | Meclizine Hcl | 111 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 108 | 26 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 108 | 40 |
| Torsemide | Torsemide | 108 | 34 |
| Austedo | Deutetrabenazine | 104 | suppressed |
| Ibuprofen | Ibuprofen | 103 | 25 |
| Lacosamide | Lacosamide | 103 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 102 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 102 | 18 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 101 | 27 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 99 | 81 |
| Fenofibrate | Fenofibrate | 99 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 99 | 20 |
| Ranolazine Er | Ranolazine | 99 | 17 |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 98 | 18 |
| Entresto | Sacubitril/Valsartan | 98 | 18 |
| Alprazolam | Alprazolam | 96 | 23 |
| Methenamine Hippurate | Methenamine Hippurate | 95 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 92 | 18 |
| Alendronate Sodium | Alendronate Sodium | 91 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 91 | 37 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 89 | 21 |
| Propranolol Hcl | Propranolol Hcl | 88 | 15 |
| Clonazepam | Clonazepam | 87 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 85 | 15 |
| Amantadine | Amantadine Hcl | 84 | 12 |
| Dexamethasone | Dexamethasone | 81 | 74 |
| Promethazine Hcl | Promethazine Hcl | 81 | 28 |
| Clonidine | Clonidine | 80 | 15 |
| Glipizide Er | Glipizide | 79 | 17 |
| Doxepin Hcl | Doxepin Hcl | 78 | 13 |
| Novolog | Insulin Aspart | 78 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 77 | 67 |
| Budesonide | Budesonide | 77 | 19 |
| Morphine Sulfate Er | Morphine Sulfate | 76 | 13 |
| Azithromycin | Azithromycin | 75 | 59 |
| Humalog Kwikpen U-100 | Insulin Lispro | 75 | 17 |
| Lithium Carbonate | Lithium Carbonate | 73 | suppressed |
| Bupropion Xl | Bupropion Hcl | 72 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 72 | 56 |
| Warfarin Sodium | Warfarin Sodium | 72 | 13 |
| Spiriva Handihaler | Tiotropium Bromide | 71 | 15 |
| Topiramate | Topiramate | 71 | 14 |
| Brilinta | Ticagrelor | 70 | suppressed |
| Xtampza Er | Oxycodone Myristate | 70 | suppressed |
| Cephalexin | Cephalexin | 69 | 63 |
| Gentamicin Sulfate | Gentamicin Sulfate | 69 | 49 |
| Trulicity | Dulaglutide | 69 | 15 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 68 | 22 |
| Humalog | Insulin Lispro | 66 | 14 |
| Solifenacin Succinate | Solifenacin Succinate | 66 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 63 | 11 |
| Movantik | Naloxegol Oxalate | 63 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 62 | 19 |
| Calcitriol | Calcitriol | 61 | suppressed |
| Celecoxib | Celecoxib | 61 | 13 |
| Ezetimibe | Ezetimibe | 60 | 12 |
| Scopolamine | Scopolamine | 60 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 58 | 27 |
| Atenolol | Atenolol | 58 | 14 |
| Diltiazem Hcl | Diltiazem Hcl | 58 | 11 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 58 | suppressed |
| Haloperidol | Haloperidol | 57 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 57 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 56 | suppressed |
| Lactulose | Lactulose | 55 | 22 |
| Levemir Flexpen | Insulin Detemir | 55 | 19 |
| Acyclovir | Acyclovir | 54 | 17 |
| Naltrexone Hcl | Naltrexone Hcl | 54 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 54 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 53 | 12 |
| Carbamazepine | Carbamazepine | 53 | suppressed |
| Gemfibrozil | Gemfibrozil | 53 | suppressed |
| Nifedipine Er | Nifedipine | 53 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 53 | suppressed |
| Admelog | Insulin Lispro | 52 | 12 |
| Bumetanide | Bumetanide | 52 | suppressed |
| Nystop | Nystatin | 51 | 30 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 51 | suppressed |
| Primidone | Primidone | 51 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 51 | 13 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 50 | 20 |
| Doxazosin Mesylate | Doxazosin Mesylate | 50 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 50 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 50 | suppressed |
| Verapamil Er | Verapamil Hcl | 50 | suppressed |
| Erythromycin | Erythromycin Base | 48 | 18 |
| Invega Sustenna | Paliperidone Palmitate | 48 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 48 | 18 |
| Dapagliflozin | Dapagliflozin Propanediol | 47 | suppressed |
| Phenobarbital | Phenobarbital | 47 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 47 | suppressed |
| Riluzole | Riluzole | 47 | suppressed |
| Sulfasalazine | Sulfasalazine | 47 | suppressed |
| Acetic Acid | Acetic Acid | 46 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 46 | suppressed |
| Insulin Aspart | Insulin Aspart | 45 | 18 |
| Nuplazid | Pimavanserin Tartrate | 45 | suppressed |
| Temazepam | Temazepam | 45 | suppressed |
| Diazepam | Diazepam | 44 | suppressed |
| Mupirocin | Mupirocin | 44 | 15 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 43 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 43 | 41 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 42 | suppressed |
| Ramelteon | Ramelteon | 42 | suppressed |
| Cefdinir | Cefdinir | 41 | 38 |
| Estradiol | Estradiol | 41 | suppressed |
| Anastrozole | Anastrozole | 40 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 40 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 40 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 39 | 12 |
| Oxcarbazepine | Oxcarbazepine | 39 | suppressed |
| Vascepa | Icosapent Ethyl | 38 | suppressed |
| Belsomra | Suvorexant | 37 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 36 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 36 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 36 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 36 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 36 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 35 | suppressed |
| Fluconazole | Fluconazole | 35 | 26 |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 35 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 34 | suppressed |
| Folic Acid | Folic Acid | 34 | suppressed |
| Levemir | Insulin Detemir | 34 | 18 |
| Metronidazole | Metronidazole | 34 | 18 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 34 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 34 | suppressed |
| Calcium Acetate | Calcium Acetate | 33 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 33 | suppressed |
| Glimepiride | Glimepiride | 33 | suppressed |
| Hydrocortisone | Hydrocortisone | 33 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | suppressed |
| Xifaxan | Rifaximin | 33 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 32 | suppressed |
| Methotrexate | Methotrexate Sodium | 32 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 26 |
| Aristada | Aripiprazole Lauroxil | 31 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 31 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 31 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 31 | 26 |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 31 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 30 | suppressed |
| Chlorthalidone | Chlorthalidone | 30 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 30 | suppressed |
| Rivastigmine | Rivastigmine | 30 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 30 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 29 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 29 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 28 | 27 |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Clotrimazole | Clotrimazole | 27 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 27 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 27 | suppressed |
| Ertapenem | Ertapenem Sodium | 27 | 22 |
| Insulin Lispro | Insulin Lispro | 27 | 14 |
| Spiriva Respimat | Tiotropium Bromide | 27 | 12 |
| Tiotropium Bromide | Tiotropium Bromide | 27 | 13 |
| Valsartan | Valsartan | 27 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 26 | suppressed |
| Renvela | Sevelamer Carbonate | 26 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 26 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 25 | suppressed |
| Leflunomide | Leflunomide | 25 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 25 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 25 | suppressed |
| Valproic Acid | Valproic Acid | 25 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 25 | suppressed |
| Cilostazol | Cilostazol | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Paliperidone Er | Paliperidone | 24 | suppressed |
| Fentanyl | Fentanyl | 23 | suppressed |
| Pindolol | Pindolol | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Restasis | Cyclosporine | 23 | suppressed |
| Roflumilast | Roflumilast | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 23 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 22 | suppressed |
| Cholestyramine Light | Cholestyramine | 22 | suppressed |
| Constulose | Lactulose | 22 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 16 |
| Novolin R | Insulin Regular, Human | 22 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 22 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 21 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 20 |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 21 | 13 |
| Minoxidil | Minoxidil | 21 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 20 | 16 |
| Trimethoprim | Trimethoprim | 20 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 19 | suppressed |
| Glyburide | Glyburide | 19 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Methimazole | Methimazole | 19 | suppressed |
| Methylprednisolone | Methylprednisolone | 19 | 18 |
| Mirabegron Er | Mirabegron | 19 | 11 |
| Sps | Sodium Polystyrene Sulfon/Sorb | 19 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 18 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | 14 |
| Humulin R | Insulin Regular, Human | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Rexulti | Brexpiprazole | 18 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 18 | suppressed |
| Alogliptin | Alogliptin Benzoate | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 17 | suppressed |
| Linezolid | Linezolid | 17 | 16 |
| Lovastatin | Lovastatin | 17 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 17 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Austedo Xr | Deutetrabenazine | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 16 | suppressed |
| Klayesta | Nystatin | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Telmisartan | Telmisartan | 16 | suppressed |
| Trospium Chloride | Trospium Chloride | 16 | suppressed |
| Dulera | Mometasone/Formoterol | 15 | suppressed |
| Fanapt | Iloperidone | 15 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Ofloxacin | Ofloxacin | 15 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 15 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 14 | suppressed |
| Cimetidine | Cimetidine | 14 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Abilify Maintena | Aripiprazole | 13 | suppressed |
| Acamprosate Calcium | Acamprosate Calcium | 13 | suppressed |
| Aliskiren | Aliskiren Hemifumarate | 13 | suppressed |
| Aripiprazole Odt | Aripiprazole | 13 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Eplerenone | Eplerenone | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Etodolac | Etodolac | 13 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 13 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Zafirlukast | Zafirlukast | 13 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Abiraterone Acetate | Abiraterone Acetate | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Budesonide Dr | Budesonide | 11 | suppressed |
| Buprenorphine | Buprenorphine | 11 | suppressed |
| Clozapine Odt | Clozapine | 11 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 11 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 11 | suppressed |
| Glucagon Emergency Kit | Glucagon | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 11 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Sotalol Af | Sotalol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $283.74 · 9 records | ACADIA Pharmaceuticals Inc | ARISTADA, INGREZZA, LYBALVI, NUPLAZID, REXULTI, ZENPEP | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Aristada play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error